Menu
PacPremier
Magic Hour
Montecito
SoCal Gas
Loading...
You are here:  Home  >  'Amgen'  -  Page 3
Latest

Amgen gets FDA approval for potential billion-dollar drug

By   /  Friday, May 28th, 2021  /  Banking & Finance, Biotech, East Ventura County, Latest news, right, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen gets FDA approval for potential billion-dollar drug

Thousand Oaks-based Amgen won approval from the U.S. Food and Drug Administration on May 28 for its latest oral drug treatment, Lumakras, potentially adding another huge market for one of the largest biotech firms in the world. According to the Wall Street Journal, Amgen will charge $17,900 a month for the drug and analyst think Read More →

Read More →
Latest

Direct Relief comes to India’s aid during COVID crisis

By   /  Friday, May 14th, 2021  /  Central Coast Health Watch, Latest news, middle, Nonprofits, Subscriber content, Top Stories  /  Comments Off on Direct Relief comes to India’s aid during COVID crisis

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen planning apartments on its land in Thousand Oaks

By   /  Friday, May 7th, 2021  /  Biotech, East Ventura County, Latest news, Real Estate, Subscriber content, Top Stories, Tri-County Economy  /  Comments Off on Amgen planning apartments on its land in Thousand Oaks

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen CEO again tops list of region’s highest paid execs

By   /  Friday, April 30th, 2021  /  Banking & Finance, Latest news, Top Stories, Tri-County Public Companies  /  Comments Off on Amgen CEO again tops list of region’s highest paid execs

Robert Bradway remained the highest paid executive in the Tri-Counties in 2020, but stock options and new faces changed a lot of the names and positions on the list. Bradway, the CEO of Amgen, earned $20.13 million in total compensation in 2020 — 3% more than he earned in 2019, and 8.23% more than in Read More →

Read More →
Latest

Amgen stock tumbles after earnings report

By   /  Tuesday, April 27th, 2021  /  Banking & Finance, Biotech, Earnings, East Ventura County, middle, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen stock tumbles after earnings report

Editor’s note: This article was updated at 8:35 a.m. on April 28 with up-to-date information on Amgen’s stock price. Amgen’s shares fell nearly 8% following the company’s April 27 release of its first quarter 2021 earnings, which saw a decline in both revenue and net income compared to a year earlier. Amgen is headquartered in Read More →

Read More →
Latest

Amgen announces $721M acquisition

By   /  Tuesday, March 30th, 2021  /  Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, left, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen announces $721M acquisition

Amgen reported its second major acquisition of the month, as the Thousand Oaks-based firm announced March 30 that it will acquire Rodeo Therapeutics Corporation, a privately held biotech company based in Seattle. The deal is worth more than $700 million, $55 million of which will be paid upfront, with up to $666 million more in Read More →

Read More →
Latest

Amgen to buy cancer treatment biotech firm for $1.9B

By   /  Thursday, March 4th, 2021  /  Banking & Finance, Biotech, East Ventura County, Latest news, middle, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen to buy cancer treatment biotech firm for $1.9B

Thousand Oaks-based Amgen, one of the biggest biotech companies in the world, will get bigger with the $1.9 billion acquisition of Five Prime Therapeutics, a clinical-stage biotech company developing stomach cancer therapies. Amgen announced the acquisition March 4 and the deal is expected to close by the end of the second quarter of 2021. Under Read More →

Read More →